cash flow reconciliationreview2026-03-31
Operating, investing and financing flows differ from the reported change in cash by 136000000, beyond tolerance 54550000.00.
Revenue
$19.15B
Fiscal year ended 2026-06-30Net income
$736.00M
Fiscal year ended 2026-06-30Total assets
$759.37B
Fiscal year ended 2026-06-30METLIFE INC (MET) reported revenue of $19.15B and net income of $736.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from METLIFE INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Life Insurance.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.15B | $19.07B | $23.81B | $17.36B | $17.34B | $18.57B | $556.00M | $18.44B | $17.82B | $16.06B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $1.60B | $1.63B | $1.68B | $1.65B | $1.39B | $1.42B | $1.49B | $1.44B | $1.66B | $1.40B |
| Net income | $736.00M | $1.18B | $809.00M | $896.00M | $729.00M | $945.00M | $1.27B | $1.34B | $946.00M | $867.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 646.90M | shares 655.70M | Unavailable | shares 669.10M | shares 675.00M | shares 687.00M | Unavailable | shares 703.70M | shares 714.70M | shares 728.40M |
| Pretax income | $1.04B | $1.51B | $1.12B | $1.21B | $980.00M | $1.35B | $1.38B | $1.99B | $1.20B | $1.04B |
| Income tax expense | $256.00M | $345.00M | $301.00M | $308.00M | $245.00M | $404.00M | $106.00M | $653.00M | $249.00M | $170.00M |
| Diluted EPS | $1.09 | $1.74 | Unavailable | $1.22 | $1.03 | $1.28 | Unavailable | $1.81 | $1.28 | $1.10 |
| Selling, general & administrative | $2.19B | $2.16B | $2.06B | $1.88B | $1.74B | $1.67B | $1.56B | $1.68B | $1.62B | $1.65B |
| General & administrative | $154.00M | $132.00M | $186.00M | $118.00M | $130.00M | $126.00M | $18.00M | $162.00M | $153.00M | $148.00M |
| Selling & marketing | $2.03B | $2.03B | $1.87B | $1.77B | $1.61B | $1.55B | $1.54B | $1.52B | $1.46B | $1.50B |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | $21.33B | $20.07B | $21.76B | $20.79B | $19.84B |
| Total assets | $759.37B | $743.21B | $745.17B | $719.73B | $702.47B | $688.32B | $677.46B | $704.98B | $675.74B | $677.58B |
| Current assets | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total liabilities | $731.41B | $715.41B | $716.24B | $690.54B | $674.54B | $660.56B | $649.75B | $673.81B | $648.20B | $648.78B |
| Current liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $27.74B | $27.60B | $28.68B | $29.19B | $27.93B | $27.76B | $27.70B | $31.16B | $27.54B | $28.80B |
| Temporary (mezzanine) equity | $220.00M | $206.00M | $241.00M | Unavailable | Unavailable | Unavailable | $0 | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $370.00M | $393.00M | $272.00M | $280.00M | $265.00M | $254.00M | $238.00M | $245.00M | $231.00M | $251.00M |
| Goodwill | $9.54B | $9.56B | $9.61B | $9.10B | $9.14B | $9.04B | $8.90B | $9.16B | $8.95B | $9.04B |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B | $4.17B | $3.49B | $2.33B |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$8.87B | -$5.46B | -$4.29B | -$5.02B | -$2.98B | -$3.32B | -$5.36B | -$2.16B | -$1.34B | -$2.63B |
| Financing cash flow | $3.22B | $3.56B | -$998.00M | -$508.00M | $1.45B | $220.00M | -$519.00M | -$1.15B | -$1.20B | -$261.00M |
| Net change in cash | -$3.39B | $655.00M | $1.80B | -$1.94B | $852.00M | $1.26B | -$1.70B | $979.00M | $946.00M | -$799.00M |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common dividends paid | $383.00M | $372.00M | $375.00M | $378.00M | $382.00M | $374.00M | $378.00M | $383.00M | $389.00M | $377.00M |
| Common share repurchases | $722.00M | $755.00M | $460.00M | $502.00M | $510.00M | $1.41B | $406.00M | $774.00M | $855.00M | $1.17B |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 8.4% | 8.6% | 7.1% | 9.5% | 8.0% | 7.6% | 268.2% | 7.8% | 9.3% | 8.7% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | 10.5% | 2.7% | 4183.1% | -5.9% | -2.7% | 15.6% | -97.1% | 16.2% | 7.2% | 4.3% |
| Net margin | 3.8% | 6.2% | 3.4% | 5.2% | 4.2% | 5.1% | 228.6% | 7.3% | 5.3% | 5.4% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 24.7% | 22.9% | 26.9% | 25.5% | 25.0% | 29.8% | 7.7% | 32.7% | 20.7% | 16.3% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MET in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-01View SEC filing
Reconciliation checks needing review
12 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2025-06-30
Operating, investing and financing flows differ from the reported change in cash by 197000000, beyond tolerance 29810000.00.
cash flow reconciliationreview2025-03-31
Operating, investing and financing flows differ from the reported change in cash by 98000000, beyond tolerance 42620000.00.
cash flow reconciliationreview2024-12-31
Operating, investing and financing flows differ from the reported change in cash by 425000000, beyond tolerance 53640000.00.
cash flow reconciliationreview2024-09-30
Operating, investing and financing flows differ from the reported change in cash by 118000000, beyond tolerance 41690000.00.
cash flow reconciliationreview2024-03-31
Operating, investing and financing flows differ from the reported change in cash by 239000000, beyond tolerance 26270000.00.
cash flow reconciliationreview2023-12-31
Operating, investing and financing flows differ from the reported change in cash by 145000000, beyond tolerance 51820000.00.
cash flow reconciliationreview2023-09-30
Operating, investing and financing flows differ from the reported change in cash by 160000000, beyond tolerance 34750000.00.
cash flow reconciliationreview2023-06-30
Operating, investing and financing flows differ from the reported change in cash by 110000000, beyond tolerance 63460000.00.
cash flow reconciliationreview2023-03-31
Operating, investing and financing flows differ from the reported change in cash by 34000000, beyond tolerance 22950000.00.
cash flow reconciliationreview2022-12-31
Operating, investing and financing flows differ from the reported change in cash by 359000000, beyond tolerance 44680000.00.
balance equationreview2022-09-30
Difference 4310000000 exceeds tolerance 650104000.000. Presentation or filing-vintage differences need review.